GlassScriptPhysician profile
Hersh Chopra
NPI 1962463570
$16,190.91
in general payments reported to CMS, 2019-2025
28 companies · $1,997 in 2025
The $1,997 reported for 2025 was more than what 88% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $628 · 2020: $374 · 2021: $496 · 2022: $555 · 2023: $992 · 2024: $11K · 2025: $1,997.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Food and Beverage: $4,138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,000.00 |
| Food and Beverage | $4,137.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $10,257.09 | 2022-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Glaukos Corporation | $1,180.98 | 2024-2025 | Idosetr, Radius, Istent Trabecular Micro-Bypass System Model Is3 |
| Alcon Vision LLC | $860.25 | 2019-2025 | Clareon, Rhopressa, Rocklatan |
| Abbvie INC. | $821.91 | 2022-2025 | Lumigan, Alphagan P, Vuity |
| Allergan, INC. | $354.97 | 2019-2022 | |
| Sight Sciences, INC. | $352.40 | 2020-2025 | Omni Surgical System, Sion Surgical Instrument |
| Eyepoint US, INC. | $271.12 | 2019 | |
| New World Medical,INC. | $229.66 | 2025 | Streamline, Via360, Kahook Dual Blade |
| Aerie Pharmaceuticals, INC. | $219.78 | 2019-2021 | |
| Astellas Pharma US INC | $192.62 | 2023-2024 | Izervay |
| Bausch & Lomb Americas INC. | $173.15 | 2022-2025 | Vyzulta, Miebo, Xiidra |
| Biotissue Holdings INC. | $169.21 | 2023-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $157.32 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $124.98 | 2019 | |
| Oyster Point Pharma, INC. | $118.66 | 2023-2025 | Tyrvaya |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $117.88 | 2019-2023 | Cequa |
| Coopervision INC. | $105.38 | 2023 | Clariti Contact Lens |
| Dompe US, INC. | $89.82 | 2021-2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $69.90 | 2024-2025 | Xdemvy |
| Akorn Operating Company LLC | $50.64 | 2021 | |
| Mallinckrodt Hospital Products INC. | $44.38 | 2021-2022 | |
| Akorn, INC. | $43.40 | 2020 | |
| Amgen INC. | $41.87 | 2025 | Tepezza |
| Horizon Therapeutics Plc | $41.31 | 2021-2023 | Tepezza |
| Ani Pharmaceuticals, INC. | $39.03 | 2025 | Purified Cortrophin Gel |
| Thea Pharma INC. | $24.76 | 2023 | Iyuzeh |
| Harrow Eye, LLC | $20.71 | 2024 | Vevye |
| Ivantis, INC | $17.73 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hersh Chopra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.